skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.06d (Release date: 2017-06-26)
SearchBox Top
SearchBox Bottom
Beta-glucan/Lactobacillus casei/Bifidobacterium lactis-based Supplement (Code C99227)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: Beta-glucan/Lactobacillus casei/Bifidobacterium lactis-based Supplement

Definition: A synbiotic supplement containing beta-1,3-glucan, bacteria Lactobacillus casei (L. casei) and Bifidobacterium lactis (B. lactis), with potential immunomodulating activity. The naturally-occurring bacterial components in this dietary supplement may improve digestion and help maintain adequate colonization of the gastrointestinal (GI) tract by modulating the composition of the normal microflora. During colonization of the GI tract, the bacteria may form a protective intestinal barrier, thereby preventing attachment of potential pathogens. Both the probiotics and beta-glucan have been shown to stimulate the immune system. This supplement also contains several vitamins and other insoluble polysaccharides.

Label: Beta-glucan/Lactobacillus casei/Bifidobacterium lactis-based Supplement

NCI Thesaurus Code: C99227 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: CL433056  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
Beta-glucan/Lactobacillus casei/Bifidobacterium lactis-based Supplement

External Source Codes: 
PDQ Closed Trial Search ID 719078
PDQ Open Trial Search ID 719078 (check for NCI PDQ open clinical trial info)

Other Properties:
     Name Value (qualifiers indented underneath)
code C99227
Semantic_Type Pharmacologic Substance

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom